KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,438,000 | -22.9% | 8,000 | -55.6% | 0.49% | -28.4% |
| Q2 2017 | $1,866,000 | +32.1% | 18,000 | 0.0% | 0.68% | +3.8% |
| Q1 2017 | $1,413,000 | +75.1% | 18,000 | 0.0% | 0.66% | +70.9% |
| Q4 2016 | $807,000 | -3.7% | 18,000 | +20.0% | 0.38% | -9.0% |
| Q3 2016 | $838,000 | -16.2% | 15,000 | -25.0% | 0.42% | -14.9% |
| Q2 2016 | $1,000,000 | -27.4% | 20,000 | -33.3% | 0.50% | -18.5% |
| Q1 2016 | $1,377,000 | – | 30,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |